Dimension Capital

Latest fund size

$800M

Announced

July 24, 2026

Global HQ

United States

Members only

Check size

$1M - $30M

Members only

Stage focus

Seed, Series A, Series B, Growth

Members only

Regions of investment

North America

Members only

About

Dimension Capital is a New York and San Francisco-based multistage venture firm founded in late 2022 by Zavain Dar, Adam Goulburn, and Nan Li, all formerly of Lux Capital and Obvious Ventures. The firm was built on the conviction that the boundary between life sciences investing and frontier software investing has effectively dissolved, and that the most important companies at this intersection require investors with genuine technical depth at both the model layer and the biology layer. In under four years, the firm has grown to $1.65B in AUM across three funds, a pace normally reserved for firms with a decade of distributions.

Contact info

dimensioncap.com

contact@dimensioncap.com

‍

Zavain Dar — Co-Founder & General Partner

zavain@dimensioncap.com

‍

Adam Goulburn — Co-Founder & General Partner

adam@dimensioncap.com

‍

Nan Li — Co-Founder & General Partner

‍

Members only

Names, roles, emails and LinkedIn profiles for the team, plus the fund's website.

Investment focus

Dimension backs companies at the intersection of science and compute: AI for biology, drug discovery, materials science research, lab automation, and adjacent hardware and infrastructure.

The firm is multistage and research-oriented, willing to co-lead seed rounds in companies with no revenue and no clinical asset where the core product is a foundation model, and following on aggressively through later rounds in its strongest positions.

‍

‍

Members only

What the fund looks for in founders and which sectors it backs.

Fund

Dimension Capital I:

Launched in 2022 with $350 million, focusing on early-stage investments in drug discovery, life sciences, machine learning, artificial intelligence, advanced manufacturing, and software sectors.

Dimension Capital II:

Closed in October 2024, raising $500 million to continue investing in startups at the intersection of technology and biology. This fund exceeded its $400 million target, reflecting strong investor interest.

Dimension III:

Closed at $800M in July 2026.

Members only

Fund size, LPs and track record.

Other information

Leadership

Zavain Dar is Co-Founder and General Partner, a Stanford University graduate and former partner at Lux Capital. Adam Goulburn is Co-Founder and General Partner, a Monash University graduate and former partner at Lux Capital, based in New York. Nan Li is Co-Founder and General Partner, formerly of Obvious Ventures. Simon Barnett is Partner. Additional team members include Michele Vlcek, Amy Zhen, and Chloe Gonzalez.

‍

Investment Strategy

Dimension operates as a multistage, research-led firm, seeding companies before their categories exist and defending ownership through large follow-on rounds.

The three-partner structure is deliberate: a small partnership with genuine technical literacy at the model layer can move faster and with more conviction on seed rounds in novel scientific categories than committees can.

The firm is unusually comfortable with pre-revenue, pre-clinical risk where the defensible asset is a model, a dataset, or an automated experimental loop.

Its multistage structure enables it to write $30M seed checks and then participate in $400M Series C rounds without syndicating away the position.

‍

Notable Investments

  • Chai Discovery
  • New Limit
  • Coefficient Bio
  • Modal Labs
  • Monte Rosa Therapeutics
  • Lantern
  • Kaleidoscope
  • Scispot

‍

Notable Exits

  • Coefficient Bio

Members only

Leadership, investment strategy, notable investments and exits.

Unlock this fund's full profile

✓ Emails and LinkedIn for the team

✓ Check size, stage focus and regions of investment

✓ LPs, notable investments and exits

✓ Search and filters across 700+ funds

Unlock this fund and 700+ more

From $14/month, billed yearly. Cancel any time.

Read the newsletter that top VCs and founders keep in their inbox.

Join the weekly newsletter